L5: Proteoglycans and Signalling Flashcards
1
Q
PG signalling: How do PGs act and why are they so diverse in effect?
A
- Signalling pathways still function in absence of PGs -> co-receptors
- PGs can influence a vast range of signalling pathways because their side chains (GAGs) are capable of huge diversity in structure
2
Q
GAGs: Structure, examples
A
- Glycosaminoglycans
- Repeating disaccharide of around 80 sugar residues
- Each residue, apart from those of HA, may be sulphated
- e.g. chrondroitin / dermatan sulphate, keratan sulphate, hyaluronan, heparan sulphate (HS / heparin
3
Q
How are PGs structured?
A
- Core protein
- One or more GAGs attached
4
Q
Examples of cell-surface processes of PGs (beyond co-receptor activity):
A
- Dimerisation
- Two-dimensional sliding
- Surface transport
- Transcellular transport
4
Q
Families of membrane PGs (x2)
A
- Syndecans (transmembrane with core protein with HS and CS GAGs)
- Glypicans (anchored to PM via GPI, core globular domain with HS GAGs); major part of the extracellular matrix
- 4 mammalian syndecans exist, with differential tissue expression etc
- 6 mammalian glypicans exist
- In both cases, heparan sulfate is able to bind E-C ligands and modulate their interactions with cell surface receptors
5
Q
What is dally?
A
- Glypican found in drosophila (discovered as a mutation in which glypican is not being synthesised correctly, producing only a weak signal (signalling still occurs in part)
- Dally is involved in diffusion of Dpp; abnormally delays cell division -> in dally mutant the shape of the morphogen gradient is altered (shortened, doesn’t reach as far from source in short periods)
- Dally-like is needed for Hh signalling in the developing wing
- Dpp: Growth-promoting morphogen in TGFb family
5
Q
Types of concentration responses in cell signalling (x2):
A
- Cliff-edge like (defined thresholds)
- Gradient (response observed even in very small concentrations)
6
Q
Potential defects in PGs: (x3)
A
- Incorrect synthesis of core or lack of sulphation -> weak signal
- Overactive PG which does not release morphogens once bound -> weak signal
- Overactive notum -> PGs cleaved in excess, unable to localise morphogen properly -> weak signal
7
Q
Further examples of PG mutants:
A
- Sugarless (UDP glucose dehydrogenase)
- Sulphateless (sulfotransferase)
8
Q
Origin of HS diversity:
A
- Different esters on the disaccharides can be sulfated -> increasing or decreasing negative charge
- e.g. Sulfation or lack thereof at a particular position is essential for binding of certain FGFs
- e.g. specifically, HGF binding necessitates L-iduronic acid to be unsulphated
9
Q
What are Sulfs?
A
- e.g. Qsulf
- Qsulf enzymes remove sulphates -> post translational modification of PGs
- Discovered in quail
- Known to have major roles in development and cancer -> explore further?
10
Q
+ Expression of GPC3 in cancer
A
- GPC3 is overexpressed in >70% of hepatocellular carcinomas
- Not in normal adult tissues
11
Q
+ Role of Wnt in healthy adult tissues:
A
- Wnt signalling promotes tissue renewal and regeneration
- Highly hydrophobic
12
Q
+ What 4 groups of molecules do glypicans typically interact with?
A
- Morphogens
- Cytokines
- Chemokines
- Growth factors
13
Q
+ Disease associated with dysfunction of glypicans (human)
A
- SGBS (Simpson Golabi Behmel Syndrome)
- X-linked overgrowth syndrome mainly affecting males, also causes susceptibility to certain malignancies
- Associated with loss of function of GPC3
*